山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (3): 51-53.doi: 10.6040/j.issn.1673-3770.0.2014.381

• 论著 • 上一篇    下一篇

靶向人喉癌HEP2细胞Trop2基因的siRNA构建及鉴定

陈小玲1,2, 费兵1,3, 李贤斌2, 吴昊1   

  1. 1. 南通大学附属医院耳鼻咽喉头颈外科, 江苏 南通 226001;
    2. 枣阳市第一人民医院耳鼻喉科, 湖北 枣阳 441200;
    3. 金湖县人民医院耳鼻喉科, 江苏 金湖 211600
  • 收稿日期:2014-12-02 修回日期:2015-04-03 发布日期:2015-06-16
  • 通讯作者: 吴昊。E-mail:entwuhao@163.com E-mail:entwuhao@163.com
  • 作者简介:陈小玲。E-mail:chenxiaoling-321@163.com

Construction and identification of small interfering RNA targeting silence Trop2 expression in human laryngeal carcinoma cell line HEP2

CHEN Xiaoling1,2, FEI Bing1,3, LI Xianbin2, WU Hao1   

  1. 1. Department of Otolaryngology & Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China;
    2. Department of Otolaryngology, Zaoyang First People's Hospital, Zaoyang 441200, Hubei, China;
    3. Department of Otolaryngology, Jinhu People's Hospital, Jinhu 211600, Jiangsu, China
  • Received:2014-12-02 Revised:2015-04-03 Published:2015-06-16

PDF (PC)

424

摘要： 目的 构建能高效干扰Trop2基因的siRNA, 转染人喉癌HEP2细胞, 并初步鉴定其干扰效果。方法 以人Trop2基因为靶基因, 设计合成3条针对不同作用位点的siRNA干扰序列, 用脂质体法将各小干扰序列瞬时转染人喉癌HEP2细胞, 同时设立阴性对照、空白对照, 分别命名为W组(未转染组)、NC组(阴性对照组)、T1组(S1序列组)、T2组(S2序列组)及T3组(S3序列组), 每组各5例。荧光显微镜下观察绿色荧光蛋白表达, 计算转染效率。转染24 h后, 收集稳定后细胞, 采用实时荧光定量PCR法检测各干扰序列对Trop2基因表达的抑制效果。结果 荧光显微镜下观察, 见HEP2细胞表达绿色荧光蛋白, 证实siRNA已转入细胞, 转染率达90%。RT-PCR法结果显示, 与未转染组、阴性对照组相比, 转染siRNA的人喉癌HEP2细胞中Trop2表达均受到抑制, 与T2、T3组相比, T1组对Trop2 mRNA的抑制作用最明显, 差异有统计学意义(0.470±0.063 vs 0.749±0.024, 0.824±0.027, P<0.05)。结论 成功构建并筛选出了能高效、特异沉默人喉癌HEP2细胞Trop2基因的siRNA序列, 为进一步研究Trop2基因在喉癌中的作用机制及其基因治疗奠定了基础。

关键词: Trop2, HEP2细胞, 喉肿瘤, RNA干扰

Abstract: Objective To construct the small interfering RNA(siRNA) that can silence Trop2 expression and to investigate the silencing effect of siRNA on Trop2 gene in human laryngeal carcinoma cell line HEP2. Methods Three different gene sequences siRNA specific targeting Trop2 gene were constructed and used to transfect into HEP2 cells by using LipofectamineTM 2000. The negative control group and blank control group were set up at the same time. These cells were divided into the W group (un-transfection), the NC group (transfection with negative control), the T1 group(S1 sequence), the T2 group(S2 sequence) and the T3 group(S3 sequence). The transfection efficiency was reported by green fluorescence protein expression and gene inhibition efficiency was analyzed by real-time RT-PCR. Results Green fluorescence observed by fluorescence microscopy showed that siRNA had been transfected into HEP2 cells, and the transfection ratio was 90%. The expression levels of Trop2 mRNA in cells transfected with Trop2-specific siRNA were lower than those in the untransfected cells or cells transfected with negative control siRNA. Compared with the T2 and T3 groups, siRNA in the T1 group had the strongest inhibitory effect on the expression of Trop2 mRNA, and the difference was significant(0.470±0.063 vs 0.749±0.024, 0.824±0.027, P<0.05 ). Conclusion Effective siRNA sequence has been successfully constructed and selected which can inhibit the expression of Trop2 gene in human laryngeal carcinoma cell line HEP2. It is fundamental for the study on the function of Trop2 gene and the gene therapy of laryngeal carcinoma.

Key words: HEP2 cells, Laryngeal carcinoma, RNA interference, Trop2

中图分类号: 

  • R739.6
[1] RNA干扰:双链RNA引起的基因沉默机制—2006年诺贝尔生理学或医学奖成果简介[J]. 科技导报, 2006, 24 (12): 5-8.
[2] Elbashir S M, Lendeckel W, Tusch T. RNA interference is mediated by21 and 22 nucleotide RNAs[J]. Genes Dev, 2001, 15(2):188-200.
[3] Hunt K K, Vorburger S A. Hurdles and hopes for cancer treatment[J]. Science, 2002, 297(5580): 415-416.
[4] Fong D, Moser P, Krammel C, et al. High expression of Trop2 correlates with poor prognosis in pancreatic cancer[J]. Br J Cancer, 2008, 99(8):1290-1295.
[5] Fong D, Spizzo G, Gostner J M, et al. Trop2: a novel prognostic marker in squamous cell carcinoma of the oral cavity[J]. Mod Pathol, 2008, 21(2):186-191.
[6] Fang Y J, Lu Z H, Wang G Q, et al. Elevated expressions of MMP7, Trop2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer[J]. Int J Colorectal Dis, 2009, 24(8):875-884.
[7] Mühlmann G, Spizzo G, Gostner J, et al. Trop2 expression as prognostic marker for gastric carcinoma[J]. J Clin Pathol, 2009, 62(2):152-158.
[8] Bignotti E, Todeschini P, Calza S, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients[J]. Eur J Cancer, 2010, 46(5):944-953.
[9] Coldren C D, Helfrich B A, Witta S E, et al. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines[J]. Mol Cancer Res, 2006, 4(8):521-528.
[10] Wang J, Day R, Dong Y, et al. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers[J]. Mol Cancer Ther, 2008, 7(2):280-285.
[11] Wu H, Xu H, Zhang S, et al. Potential therapeutic target and independent prognostic marker of Trop2 in laryngeal squamous cell carcinoma[J]. Head Neck, 2013, 35(10):1373-1378.
[12] 傅继梁.基因工程小鼠[M].上海:上海科学技术出版社, 2006:137-161.
[13] Grimm D. Small silencing RNAs: state-of-the-art[J]. Adv Drug Deliv Rev, 2009, 61(9):672-703.
[1] 付玉贵,王海兰,孙德重,杨佩珍,陈彦林,陈志鹏. 保留部分环状软骨环的喉全切除术[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 73-75.
[2] 张明德,张祖平,于学民,魏燕红,袁英. RASSF2A基因甲基化在喉癌组织中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 64-67.
[3] 周华群,张立庆,徐朝琪,姜盼,王愿,刘晓静,董伟达. 姜黄素联合白藜芦醇抑制人头颈部肿瘤细胞系增殖的机制研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 67-72.
[4] 许元腾,陈瑞庆,林功标,方秀玲,俞舒娟,梁晓华,张榕. RNAi沉默PDCD4基因对人喉癌Hep-2细胞增殖及β-catenin表达的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 110-114.
[5] 马玲国,郑朝攀,周敬淳,张博,龚桃根,张云静. CO2激光治疗声门型喉癌远期疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 98-100.
[6] 苏甜甜,张佳综述,孙臻峰审校. 多药耐药基因蛋白P-gp和ABCG2在喉癌等头颈肿瘤中的作用及相关信号通路[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 103-106.
[7] 李盈盈, 周涵, 张伟强, 董伟达. 沉默HIF-1α基因对鼻黏膜上皮细胞生长因子表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 38-42.
[8] 王守玺, 刘荷珍. 声门上水平喉部分切除术中舌骨去留对误咽的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 45-47.
[9] 严羽, 朱江. 早期喉癌及喉癌前病变诊断的研究进展[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 80-85.
[10] 王玉红, 王倩, 陈萍, 钱晓云. 原发于喉部的非鳞状细胞癌11例并文献复习[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 83-88.
[11] 刘荷珍. 甲状软骨外膜和胸骨舌骨肌用于声门型喉癌切除喉重建临床分析[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 49-51.
[12] 田俊, 王丹丹, 皇甫辉, 王斌全, 李乐. 喉癌CT/MRI融合图像的建立及初步应用[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 52-55.
[13] 王英俊，孙彦，李薇，华辉，黄沂传，葛瑞锋，韩敏. 喉癌、喉咽癌手术相关肺血栓栓塞症的临床特点[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 51-54.
[14] 魏希建1，阴瑞兰2，郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14-16.
[15] 刘昉1，赖建新1，李瑞玉1，李冠桢2. 喉癌患者外周血中Th17/Treg比率变化[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 4-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发